Announcements Trials

Browse Landscape

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Non-Small-Cell Lung 131 Squamous Cell Carcinoma of Head and Neck 75 Lung Neoplasms 47 Head and Neck Neoplasms 45 Urinary Bladder Neoplasms 43 Parkinson Disease 4, Autosomal Dominant Lewy Body 33 Oropharyngeal Neoplasms 32 Nasopharyngeal Carcinoma 31 Biliary Tract Neoplasms 31 Uterine Cervical Neoplasms 29 Cholangiocarcinoma 28 Esophageal Squamous Cell Carcinoma 24 Neoplasms 23 Carcinoma 23 Neoplasm Metastasis 22 Small Cell Lung Carcinoma 21 Ovarian Neoplasms 21 Carcinoma, Squamous Cell 20 Stomach Neoplasms 18 Colorectal Neoplasms 18 Carcinoma, Transitional Cell 17 Pancreatic Neoplasms 16 Esophageal Neoplasms 16 Mesothelioma, Malignant 15 Gallbladder Neoplasms 15 Mouth Neoplasms 14 Laryngeal Neoplasms 13 Hypopharyngeal Neoplasms 12 Endometrial Neoplasms 11 Triple Negative Breast Neoplasms 10

Interventions

Varenicline 1 Tyrosine Kinase Inhibitors 1 Trastuzumab 1 Tobacco Use Cessation Devices 1 Registries 1 Patient Reported Outcome Measures 1 Nicotine Chewing Gum 1 Interviews as Topic 1 Cisplatin 1 Bupropion 1 Bleomycin 1 Anthracyclines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms, Second Primary × Cisplatin × 1 year × Clear all

NCT03199300 2025-12-11

InvestiCAT

University Medical Center Groningen

Active not recruiting

Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡